确定替尼列汀和二甲双胍与格列美脲和二甲双胍在单药治疗未控制的2型糖尿病患者中的疗效和安全性

{"title":"确定替尼列汀和二甲双胍与格列美脲和二甲双胍在单药治疗未控制的2型糖尿病患者中的疗效和安全性","authors":"N. Hans","doi":"10.9734/bpi/tipr/v10/11701d","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":22326,"journal":{"name":"Technological Innovation in Pharmaceutical Research Vol. 10","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Determining the Efficacy and Safety of Teneligliptin and Metformin Versus Glimepiride and Metformin in Patients of Type-2 Diabetes Mellitus Uncontrolled with Monotherapy\",\"authors\":\"N. Hans\",\"doi\":\"10.9734/bpi/tipr/v10/11701d\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":22326,\"journal\":{\"name\":\"Technological Innovation in Pharmaceutical Research Vol. 10\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Technological Innovation in Pharmaceutical Research Vol. 10\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.9734/bpi/tipr/v10/11701d\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technological Innovation in Pharmaceutical Research Vol. 10","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/bpi/tipr/v10/11701d","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}